| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2017-09-09 03:44:49 UTC |
|---|
| Update Date | 2022-11-30 19:26:04 UTC |
|---|
| HMDB ID | HMDB0115149 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | PA(20:4(5Z,8Z,11Z,14Z)/18:0) |
|---|
| Description | PA(20:4(5Z,8Z,11Z,14Z)/18:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(20:4(5Z,8Z,11Z,14Z)/18:0), in particular, consists of one chain of arachidonic acid at the C-1 position and one chain of stearic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids. |
|---|
| Structure | [H][C@@](COC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC)(COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCCCC InChI=1S/C41H73O8P/c1-3-5-7-9-11-13-15-17-19-20-22-23-25-27-29-31-33-35-40(42)47-37-39(38-48-50(44,45)46)49-41(43)36-34-32-30-28-26-24-21-18-16-14-12-10-8-6-4-2/h11,13,17,19,22-23,27,29,39H,3-10,12,14-16,18,20-21,24-26,28,30-38H2,1-2H3,(H2,44,45,46)/b13-11-,19-17-,23-22-,29-27-/t39-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 1-Arachidonoyl-2-stearoyl-sn-glycero-3-phosphate | HMDB | | 1-Arachidonoyl-2-stearoyl-sn-phosphatidic acid | HMDB | | PA(20:4/18:0) | HMDB | | PA(20:4N6/18:0) | HMDB | | PA(20:4W6/18:0) | HMDB | | PA(38:4) | HMDB | | Phosphatidic acid(20:4(5Z,8Z,11Z,14Z)/18:0) | HMDB | | Phosphatidic acid(20:4/18:0) | HMDB | | Phosphatidic acid(20:4n6/18:0) | HMDB | | Phosphatidic acid(20:4W6/18:0) | HMDB | | Phosphatidic acid(38:4) | HMDB | | Phosphatidate(20:4(5Z,8Z,11Z,14Z)/18:0) | HMDB | | Phosphatidate(20:4/18:0) | HMDB | | Phosphatidate(20:4N6/18:0) | HMDB | | Phosphatidate(20:4W6/18:0) | HMDB | | Phosphatidate(38:4) | HMDB | | 1-arachidonoyl-2-stearoyl-sn-glycero-3-phosphate | SMPDB, HMDB | | 1-arachidonoyl-2-stearoyl-sn-phosphatidic acid | SMPDB, HMDB | | PA(20:4/18:0) | SMPDB, HMDB | | PA(20:4n6/18:0) | SMPDB, HMDB | | PA(20:4w6/18:0) | SMPDB, HMDB | | PA(38:4) | SMPDB, HMDB | | Phosphatidic acid(20:4(5Z,8Z,11Z,14Z)/18:0) | SMPDB, HMDB | | Phosphatidic acid(20:4/18:0) | SMPDB, HMDB | | Phosphatidic acid(20:4n6/18:0) | SMPDB, HMDB | | Phosphatidic acid(20:4w6/18:0) | SMPDB, HMDB | | Phosphatidic acid(38:4) | SMPDB, HMDB | | Phosphatidate(20:4(5Z,8Z,11Z,14Z)/18:0) | SMPDB, HMDB | | Phosphatidate(20:4/18:0) | SMPDB, HMDB | | Phosphatidate(20:4n6/18:0) | SMPDB, HMDB | | Phosphatidate(20:4w6/18:0) | SMPDB, HMDB | | PA(20:4(5Z,8Z,11Z,14Z)/18:0) | SMPDB |
|
|---|
| Chemical Formula | C41H73O8P |
|---|
| Average Molecular Weight | 725.001 |
|---|
| Monoisotopic Molecular Weight | 724.504306309 |
|---|
| IUPAC Name | [(2R)-3-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]-2-(octadecanoyloxy)propoxy]phosphonic acid |
|---|
| Traditional Name | (2R)-3-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]-2-(octadecanoyloxy)propoxyphosphonic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@](COC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC)(COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCCCC |
|---|
| InChI Identifier | InChI=1S/C41H73O8P/c1-3-5-7-9-11-13-15-17-19-20-22-23-25-27-29-31-33-35-40(42)47-37-39(38-48-50(44,45)46)49-41(43)36-34-32-30-28-26-24-21-18-16-14-12-10-8-6-4-2/h11,13,17,19,22-23,27,29,39H,3-10,12,14-16,18,20-21,24-26,28,30-38H2,1-2H3,(H2,44,45,46)/b13-11-,19-17-,23-22-,29-27-/t39-/m1/s1 |
|---|
| InChI Key | IJHZLICWKJKFDU-OAAUCIMNSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 1,2-diacylglycerol-3-phosphates. These are glycerol-3-phosphates in which the glycerol moiety is bonded to two aliphatic chains through ester linkages. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Glycerophospholipids |
|---|
| Sub Class | Glycerophosphates |
|---|
| Direct Parent | 1,2-diacylglycerol-3-phosphates |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1,2-diacylglycerol-3-phosphate
- Fatty acid ester
- Monoalkyl phosphate
- Dicarboxylic acid or derivatives
- Fatty acyl
- Alkyl phosphate
- Phosphoric acid ester
- Organic phosphoric acid derivative
- Carboxylic acid ester
- Carboxylic acid derivative
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Organooxygen compound
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Naturally occurring processBiological processBiochemical pathwayMetabolic pathway- Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:0/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0072040)
- Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:0) (PathBank: SMP0072041)
- Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0072044)
- Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0072050)
- Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:0/20:4(5Z,8Z,11Z,14Z)/18:1(11Z)) (PathBank: SMP0079816)
- Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:0/20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)) (PathBank: SMP0079818)
- Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:0/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0079820)
- Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:0) (PathBank: SMP0079827)
- Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0079829)
- Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:0) (PathBank: SMP0079831)
- Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0095092)
- Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:0/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0095094)
- Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0095105)
- Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:0/20:4(5Z,8Z,11Z,14Z)/16:1(9Z)) (PathBank: SMP0072030)
- Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:0/20:4(5Z,8Z,11Z,14Z)/18:0) (PathBank: SMP0072031)
- Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:0/20:4(5Z,8Z,11Z,14Z)/18:1(9Z)) (PathBank: SMP0072034)
- Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0072045)
- Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0072047)
- Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0079833)
- Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0079824)
- De Novo Triacylglycerol Biosynthesis TG(20:4(5Z,8Z,11Z,14Z)/18:0/18:3(9Z,12Z,15Z)) (PathBank: SMP0016134)
- De Novo Triacylglycerol Biosynthesis TG(20:4(5Z,8Z,11Z,14Z)/18:0/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0024747)
- De Novo Triacylglycerol Biosynthesis TG(20:4(5Z,8Z,11Z,14Z)/18:0/22:2(13Z,16Z)) (PathBank: SMP0024748)
- De Novo Triacylglycerol Biosynthesis TG(20:4(5Z,8Z,11Z,14Z)/18:0/22:4(7Z,10Z,13Z,16Z)) (PathBank: SMP0024749)
- De Novo Triacylglycerol Biosynthesis TG(20:4(5Z,8Z,11Z,14Z)/18:0/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0024750)
- De Novo Triacylglycerol Biosynthesis TG(20:4(5Z,8Z,11Z,14Z)/18:0/18:4(6Z,9Z,12Z,15Z)) (PathBank: SMP0024751)
- De Novo Triacylglycerol Biosynthesis TG(20:4(5Z,8Z,11Z,14Z)/18:0/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0024752)
- De Novo Triacylglycerol Biosynthesis TG(20:4(5Z,8Z,11Z,14Z)/18:0/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0024753)
- De Novo Triacylglycerol Biosynthesis TG(20:4(5Z,8Z,11Z,14Z)/18:0/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0024754)
- De Novo Triacylglycerol Biosynthesis TG(20:4(5Z,8Z,11Z,14Z)/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0024755)
|
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 7.38 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 36.7529 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.94 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 5259.4 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 557.3 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 354.1 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 292.7 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1158.3 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 1924.1 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 1271.0 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 226.5 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 3715.8 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 1196.9 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 2941.3 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1416.2 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 756.6 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 534.8 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 855.6 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 10.9 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| PA(20:4(5Z,8Z,11Z,14Z)/18:0),1TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC | 5135.9 | Semi standard non polar | 33892256 | | PA(20:4(5Z,8Z,11Z,14Z)/18:0),1TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC | 4553.6 | Standard non polar | 33892256 | | PA(20:4(5Z,8Z,11Z,14Z)/18:0),1TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC | 5785.5 | Standard polar | 33892256 | | PA(20:4(5Z,8Z,11Z,14Z)/18:0),2TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC | 5097.6 | Semi standard non polar | 33892256 | | PA(20:4(5Z,8Z,11Z,14Z)/18:0),2TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC | 4525.8 | Standard non polar | 33892256 | | PA(20:4(5Z,8Z,11Z,14Z)/18:0),2TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC | 5048.1 | Standard polar | 33892256 | | PA(20:4(5Z,8Z,11Z,14Z)/18:0),1TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C(C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC | 5353.5 | Semi standard non polar | 33892256 | | PA(20:4(5Z,8Z,11Z,14Z)/18:0),1TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C(C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC | 4653.0 | Standard non polar | 33892256 | | PA(20:4(5Z,8Z,11Z,14Z)/18:0),1TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C(C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC | 5762.6 | Standard polar | 33892256 |
|
|---|
| MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:4(5Z,8Z,11Z,14Z)/18:0) 10V, Positive-QTOF | splash10-05r9-1091502400-70c4b8ced65d04cc010b | 2019-02-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:4(5Z,8Z,11Z,14Z)/18:0) 20V, Positive-QTOF | splash10-00kk-1192202000-c4fcc6acc1de7f30168f | 2019-02-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:4(5Z,8Z,11Z,14Z)/18:0) 40V, Positive-QTOF | splash10-01rj-1095003000-f758e04c140d81890a00 | 2019-02-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:4(5Z,8Z,11Z,14Z)/18:0) 10V, Negative-QTOF | splash10-0f9i-5095400300-8950b483c290e7a421c2 | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:4(5Z,8Z,11Z,14Z)/18:0) 20V, Negative-QTOF | splash10-004i-9032000000-f4c577f96412372397cb | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:4(5Z,8Z,11Z,14Z)/18:0) 40V, Negative-QTOF | splash10-004i-9000000000-3bba87467c91a60eb71d | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:4(5Z,8Z,11Z,14Z)/18:0) 10V, Positive-QTOF | splash10-0a6r-0000000900-f25618a4673f1c76e672 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:4(5Z,8Z,11Z,14Z)/18:0) 20V, Positive-QTOF | splash10-004i-0000005900-4871ac345f15ca0d32cd | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:4(5Z,8Z,11Z,14Z)/18:0) 40V, Positive-QTOF | splash10-00bc-0000906200-7294ef93ca5f69f9e4aa | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:4(5Z,8Z,11Z,14Z)/18:0) 10V, Positive-QTOF | splash10-0002-0000000900-c7217cc8b4fecc83cb81 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:4(5Z,8Z,11Z,14Z)/18:0) 20V, Positive-QTOF | splash10-0002-0000009900-9aeab714e87e1529316e | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:4(5Z,8Z,11Z,14Z)/18:0) 40V, Positive-QTOF | splash10-01ow-0000902300-995101269d842928660d | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:4(5Z,8Z,11Z,14Z)/18:0) 10V, Negative-QTOF | splash10-00di-0000000900-503da6078c6f482f0a70 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:4(5Z,8Z,11Z,14Z)/18:0) 20V, Negative-QTOF | splash10-0fz0-0033900400-ab040c9c4a7a7526492b | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:4(5Z,8Z,11Z,14Z)/18:0) 40V, Negative-QTOF | splash10-0ue9-1169600100-de071691e999a8613195 | 2021-09-22 | Wishart Lab | View Spectrum |
|
|---|